Skip to main content
. 2023 Feb 10;14:1062656. doi: 10.3389/fimmu.2023.1062656

Figure 7.

Figure 7

Flow cytometric evaluation of the binding ability of shark nanobodies to cells. (A) and (B) Binding of commercial anti-OGT monoclonal antibodies, shark single domain antibodies 2D9 and 3F7, to wild type H1299 cells (A) and OGT-silenced NCI-H1299 (B).